MEGHAN HARMS: Open Payments
NPI 1982949764 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$93 in 5 payments from 5 companies in 2025. Trend: 2023 $86 · 2024 $0 · 2025 $93
Food & beverage: $93
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $32 |
| Sage Therapeutics, LLC | 1 | $27 |
| Novo Nordisk Inc | 1 | $14 |
| Bioventus LLC | 1 | $14 |
| Phathom Pharmaceuticals, Inc. | 1 | $5 |
Products named: JARDIANCE, ZURZUVAE, Ozempic, XCELL, VOQUEZNA.
Industry payments across OK — which companies pay providers there.
